BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15759483)

  • 1. [Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].
    Paleev NR; Isakov VA; Ivanova OV
    Klin Med (Mosk); 2005; 83(1):9-14. PubMed ID: 15759483
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of gastroesophageal reflux on the course and therapy of bronchial asthma].
    Samoliński B
    Pol Merkur Lekarski; 2006 Oct; 21(124):307-9. PubMed ID: 17205765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attention! Cough, asthma and Co. are often caused by reflux].
    MMW Fortschr Med; 2004 Nov; 146(45):61. PubMed ID: 15581112
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastroesophageal reflux and bronchial asthma].
    Parkhomenko LK; Radbil' OS
    Klin Med (Mosk); 1994; 72(6):4-7. PubMed ID: 7898007
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remarkably many asthma patients have reflux. Asthma--a case for PPI?].
    MMW Fortschr Med; 2004 Jul; 146(29-30):8, 10. PubMed ID: 15540549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of antireflux therapy in asthmatic children with gastroesophageal reflux disease].
    Farcău D; Dreghiciu D; Cherecheş-Panţa P; Popa M; Farcău M; Nanulescu M
    Pneumologia; 2004; 53(4):207-11. PubMed ID: 16106733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and current management of gastrooesophageal-reflux-related asthma.
    Menes T; Lelcuk S; Spivak H
    Eur J Surg; 2000 Aug; 166(8):596-601. PubMed ID: 11003425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux and histamine2 antagonists.
    Bell SG
    Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    Leite LP; Just RJ; Castell DO; Lagerström PO
    Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis.
    Bate CM; Green JR; Axon AT; Tildesley G; Murrays FE; Owen SM; Emmas C; Taylor MD
    Aliment Pharmacol Ther; 1998 Jan; 12(1):41-7. PubMed ID: 9692699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-suppressing drugs during pregnancy.
    Lalkin A; Magee L; Addis A; Loebstein R; Koren G
    Can Fam Physician; 1997 Nov; 43():1923-4, 1927. PubMed ID: 9386876
    [No Abstract]   [Full Text] [Related]  

  • 15. Acid suppression and upper GI bleeding.
    Netzer P; Inauen W
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1104-5. PubMed ID: 10930909
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.
    Orr WC; Mellow MH; Grossman MR
    Aliment Pharmacol Ther; 1995 Oct; 9(5):571-4. PubMed ID: 8580280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In support of "step-up therapy" for gastroesophageal reflux disease.
    Beck IT
    Am J Gastroenterol; 2002 Feb; 97(2):503-4. PubMed ID: 11866309
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.